0000905718-15-000535.txt : 20150611 0000905718-15-000535.hdr.sgml : 20150611 20150611181554 ACCESSION NUMBER: 0000905718-15-000535 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150609 FILED AS OF DATE: 20150611 DATE AS OF CHANGE: 20150611 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CANCER GENETICS, INC CENTRAL INDEX KEY: 0001349929 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 043462475 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 201 ROUTE 17 NORTH STREET 2: 2ND FLOOR CITY: RUTHERFORD STATE: NJ ZIP: 07070 BUSINESS PHONE: 201.528.9200 MAIL ADDRESS: STREET 1: 201 ROUTE 17 NORTH STREET 2: 2ND FLOOR CITY: RUTHERFORD STATE: NJ ZIP: 07070 FORMER COMPANY: FORMER CONFORMED NAME: CANCER GENETICS INC DATE OF NAME CHANGE: 20060117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chaganti Raju S.K. CENTRAL INDEX KEY: 0001550335 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35817 FILM NUMBER: 15927018 MAIL ADDRESS: STREET 1: 201 ROUTE 17 NORTH STREET 2: 2ND FLOOR CITY: RUTHERFORD STATE: NJ ZIP: 07070 4 1 chaganti_fm4jun92015.xml OWNERSHIP DOCUMENT X0306 4 2015-06-09 0 0001349929 CANCER GENETICS, INC CGIX 0001550335 Chaganti Raju S.K. 201 ROUTE 17 NORTH 2ND FLOOR RUTHERFORD NJ 07070 1 0 0 0 Common Stock, par value $0.0001 per share 2015-06-09 4 S 0 7737 12.0129 D 176240 D Common Stock, par value $0.0001 per share 2015-06-10 4 S 0 22817 12.0261 D 153423 D Common Stock, par value $0.0001 per share 2015-06-11 4 S 0 15900 12.0452 D 137523 D The sales reported in this Form 4 were effected pursuant to a Rule 10b-5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were exercised in multiple transactions at prices ranging from $12.00 to $12.05, inclusive. The reporting person undertakes to provide Cancer Genetics, Inc., any security holder of Cancer Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares exercised at each separate price within the ranges set forth in footnote (2) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were exercised in multiple transactions at prices ranging from $12.00 to $12.15, inclusive. The reporting person undertakes to provide Cancer Genetics, Inc., any security holder of Cancer Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares exercised at each separate price within the ranges set forth in footnote (3) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were exercised in multiple transactions at prices ranging from $12.00 to $12.16, inclusive. The reporting person undertakes to provide Cancer Genetics, Inc., any security holder of Cancer Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares exercised at each separate price within the ranges set forth in footnote (4) to this Form 4. /s/ Raju S.K. Chaganti by Edward J. Sitar, Attorney-in-Fact 2015-06-11